Analysis_NN
of_IN
myeloid-associated_JJ
genes_NNS
in_IN
human_JJ
hematopoietic_JJ
progenitor_NN
cells_NNS
._.

The_DT
distribution_NN
of_IN
myeloid_JJ
lineage-associated_JJ
cytokine_NN
receptors_NNS
and_CC
lysosomal_JJ
proteins_NNS
was_VBD
analyzed_VBN
in_IN
human_JJ
CD34_NN
+_CC
cord_NN
blood_NN
cell_NN
-LRB-_-LRB-
CB_NN
-RRB-_-RRB-
subsets_NNS
at_IN
different_JJ
stages_NNS
of_IN
myeloid_JJ
commitment_NN
by_IN
reverse-transcriptase_NN
polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
RT-PCR_NN
-RRB-_-RRB-
._.

The_DT
highly_RB
specific_JJ
granulomonocyte-associated_JJ
lysosomal_JJ
proteins_NNS
myeloperoxidase_NN
-LRB-_-LRB-
MPO_NN
-RRB-_-RRB-
and_CC
lysozyme_NN
-LRB-_-LRB-
LZ_NN
-RRB-_-RRB-
,_,
as_RB
well_RB
as_IN
the_DT
transcription_NN
factor_NN
PU_NN
.1_CD
,_,
were_VBD
already_RB
detectable_JJ
in_IN
the_DT
most_RBS
immature_JJ
CD34_NN
+_CC
Thy-1_NN
+_CC
subset_NN
._.

Messenger_NN
RNA_NN
-LRB-_-LRB-
mRNA_NN
-RRB-_-RRB-
levels_NNS
for_IN
the_DT
granulocyte-colony_JJ
stimulating_NN
factor_NN
-LRB-_-LRB-
G-CSF_NN
-RRB-_-RRB-
receptor_NN
,_,
granulocyte-macrophage_NN
-LRB-_-LRB-
GM_NN
-RRB-_-RRB-
-_:
CSF_NN
receptor_NN
alpha_NN
subunit_NN
and_CC
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
receptors_NNS
I_NN
-LRB-_-LRB-
p55_NN
-RRB-_-RRB-
and_CC
II_CD
-LRB-_-LRB-
p75_NN
-RRB-_-RRB-
were_VBD
also_RB
detected_VBN
in_IN
this_DT
subset_NN
in_IN
addition_NN
to_TO
c-kit_NN
and_CC
flt-3_NN
,_,
receptors_NNS
known_VBN
to_TO
be_VB
expressed_VBN
on_IN
progenitor_NN
cells_NNS
._.

By_IN
contrast_NN
,_,
the_DT
monocyte-macrophage_JJ
colony_NN
stimulating_NN
factor_NN
-LRB-_-LRB-
M-CSF_NN
-RRB-_-RRB-
receptor_NN
was_VBD
largely_RB
absent_JJ
at_IN
this_DT
stage_NN
and_CC
in_IN
the_DT
CD34_NN
+_CC
Thy-1-CD45RA_NN
-_:
subsets_NNS
._.

The_DT
M-CSF_NN
receptor_NN
was_VBD
first_RB
detectable_JJ
in_IN
the_DT
myeloid-committed_JJ
CD34_NN
+_CC
Thy-l-CD45RA_NN
+_CC
subset_NN
._.

All_DT
other_JJ
molecules_NNS
studied_VBN
were_VBD
found_VBN
to_TO
be_VB
expressed_VBN
at_IN
this_DT
stage_NN
of_IN
differentiation_NN
._.

Different_JJ
cocktails_NNS
of_IN
the_DT
identified_VBN
ligands_NNS
were_VBD
added_VBN
to_TO
sorted_VBN
CD34_NN
+_CC
Thy-1_NN
+_CC
single_JJ
cells_NNS
._.

Low_JJ
proliferative_JJ
capacity_NN
was_VBD
observed_VBN
after_IN
1_CD
week_NN
in_IN
culture_NN
in_IN
the_DT
presence_NN
of_IN
stem_NN
cell_NN
factor_NN
-LRB-_-LRB-
SCF_NN
-RRB-_-RRB-
+_CC
Flt-3_NN
ligand_NN
-LRB-_-LRB-
FL_NN
-RRB-_-RRB-
+_CC
G-CSF_NN
._.

Addition_NN
of_IN
GM-CSF_NN
to_TO
this_DT
basic_JJ
cocktail_NN
consistently_RB
increased_VBD
the_DT
clonogenic_JJ
capacity_NN
of_IN
single_JJ
CD34_NN
+_CC
Thy-1_NN
+_CC
cells_NNS
,_,
and_CC
this_DT
effect_NN
was_VBD
further_RB
enhanced_VBN
-LRB-_-LRB-
up_RB
to_TO
72.3_CD
+_CC
\/_CD
-_:
4.3_CD
%_NN
on_IN
day_NN
7_CD
-RRB-_-RRB-
by_IN
the_DT
inclusion_NN
of_IN
TNF-alpha_NN
._.

In_IN
conclusion_NN
,_,
the_DT
presence_NN
of_IN
myeloid-associated_JJ
growth_NN
factor_NN
receptor_NN
transcripts_NNS
in_IN
CD34_NN
+_CC
CB_NN
subsets_NNS
does_VBZ
not_RB
discriminate_VB
the_DT
various_JJ
stages_NNS
of_IN
differentiation_NN
,_,
with_IN
the_DT
exception_NN
of_IN
the_DT
M-CSF_NN
receptor_NN
._.

In_IN
addition_NN
,_,
we_PRP
show_VBP
that_IN
TNF-alpha_NN
is_VBZ
a_DT
potent_JJ
costimulatory_JJ
factor_NN
of_IN
the_DT
very_RB
immature_JJ
CD34_NN
+_CC
Thy-1_NN
+_CC
CB_NN
subset_NN
._.

